Company / Current Liabilities
Cytek Biosciences, Inc. Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$77.8M
FY2025
5-year range
$33.2M / $77.8M
FY2021-FY2025
Trend
+15.0%
vs FY2024
Sector context
#133 of 160
Health Care
What the data says
Cytek Biosciences, Inc.'s current liabilities of $78M is lower than 83% of companies in the Health Care sector (FY2025). Current Liabilities has increased for 5 consecutive years, from $27M in FY2020 to $78M in FY2025.
Based on SEC 10-K filings.
$78M in FY2025 with a 5-year CAGR of +24.0%.
Increased from $56M to $78M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +16.6%
- 5-Year CAGR
- +24.0%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 160This company $77.8M Sector average $4.5B
▼
-98.3% below sector average
Key checks
Key Insights
- Cytek Biosciences, Inc.'s current liabilities has grown for 5 consecutive years.
- 5-year CAGR of +24.0%, indicating consistent growth.
- In FY2025, current liabilities increased 15.0% year-over-year.
- Ranks #133 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $77.8M | +15.0% |
| FY2024 | $67.7M | +20.3% |
| FY2023 | $56.2M | +14.7% |
| FY2022 | $49.0M | +47.8% |
| FY2021 | $33.2M | +25.0% |
| FY2020 | $26.5M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026